Functional outcomes of intramuscular botulinum toxin type a in the upper limbs of children with cerebral palsy: a phase II trial1  Margaret A Wallen, MA, BAppScOT, Stephen J O’Flaherty, MB ChB, MD, Mary-Clare A Waugh, MBBS  Archives of Physical Medicine and Rehabilitation  Volume 85, Issue 2, Pages 192-200 (February 2004) DOI: 10.1016/j.apmr.2003.05.008

Fig 1 Parents’ ratings of child’s muscle tone, use, and smoothness of movement (1=least impaired, 10=most impaired). Archives of Physical Medicine and Rehabilitation 2004 85, 192-200DOI: (10.1016/j.apmr.2003.05.008)

Fig 2 Parents’ ratings of ROM at the elbow, wrist, fingers, and thumb for all participants (1=least impaired, 10=most impaired). Archives of Physical Medicine and Rehabilitation 2004 85, 192-200DOI: (10.1016/j.apmr.2003.05.008)

Fig 3 MAS scores for elbow, wrist, and supination (0=normal, 4=rigid) for (A) the injected-muscle groups and (B) the whole sample. Archives of Physical Medicine and Rehabilitation 2004 85, 192-200DOI: (10.1016/j.apmr.2003.05.008)

Fig 4 Tardieu score on angle of first catch for (A) the whole sample and (B) the injected muscles. Archives of Physical Medicine and Rehabilitation 2004 85, 192-200DOI: (10.1016/j.apmr.2003.05.008)